United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$311.04 USD
-6.01 (-1.90%)
Updated Jul 3, 2024 01:00 PM ET
After-Market: $311.08 +0.04 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
UTHR 311.04 -6.01(-1.90%)
Will UTHR be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for UTHR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for UTHR
Merck (MRK) Gets CHMP Nod for PAH Drug Winrevair in Europe
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
UTHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Here's Why United Therapeutics (UTHR) is a Strong Value Stock
Here's Why United Therapeutics (UTHR) is a Strong Value Stock
Other News for UTHR
Chart Of The Day: United Therapeutics - Drugs For Chronic Illnesses
Catalyst Watch: Tesla deliveries, Constellation Brands earnings, and the June Jobs Report
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
United Therapeutics Shareholders Show Strong Support at Annual Meeting
United Therapeutics (UTHR) Gets a Buy from Oppenheimer